Congenital heart disease (CHD) patients have an increased prevalence of extracardiac
congenital anomalies (CAs) and risk of neurodevelopmental disabilities (NDDs). Exome …

Congenital heart disease (CHD) is the leading cause of mortality from birth defects. Here,
exome sequencing of a single cohort of 2,871 CHD probands, including 2,645 parent–…

This review provides an updated summary of the state of our knowledge of the genetic
contributions to the pathogenesis of congenital heart disease. Since 2007, when the initial …

Peroxisome proliferator–activated receptor (PPAR)-γ is required for adipogenesis but is also
found in the cardiovascular system, where it has been proposed to oppose inflammatory …

Objectives : The aim of this study was to determine the efficacy of implantable cardioverter-defibrillators
(ICDs) in children and adolescents with hypertrophic cardiomyopathy (HCM). …

Mutations that cause defects in levels of the signaling lipid phosphatidylinositol 3,5-bisphosphate
[PI(3,5)P 2 ] lead to profound neurodegeneration in mice. Moreover, mutations in …

Background: Hypertrophic cardiomyopathy is the leading cause of sudden cardiac death (SCD)
in children and young adults. Our objective was to develop and validate a SCD risk …

Hypertrophic cardiomyopathy (HCM) is often caused by pathogenic variants in sarcomeric
genes and characterized by left ventricular (LV) hypertrophy, myocardial fibrosis and …

For pediatric rare diseases, the number of patients available to support traditional research
methods is often inadequate. However, patients who have similar diseases cluster “virtually” …

Background: The Fontan operation creates a total cavopulmonary connection, a circulation
in which the importance of pulmonary vascular resistance is magnified. Over time, this …